Abbott Laboratories (BCBA:ABT)

Market Cap	289.46T
Revenue (ttm)	51.37T
Net Income (ttm)	16.60T
Shares Out	n/a
EPS (ttm)	9,499.81
PE Ratio	17.44
Forward PE	23.62
Dividend	479.18 (1.13%)
Ex-Dividend Date	Jul 15, 2025

Volume	548
Average Volume	1,616
Open	41,500
Previous Close	41,325
Day's Range	41,500 - 42,600
52-Week Range	30,325 - 43,925
Beta	n/a
RSI	59.34
Earnings Date	Jul 17, 2025

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: ABT

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD